4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000950170-24-012394
Options or other derivatives
- Chief Financial Officer acquired 371,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Moran Kyle · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-05 | Grant or award : show line 1 in the form Share Option (right to buy) | +371,500 | 371,500 | D |
Loading xslF345X05/ownership.xml…